A detailed history of Great Valley Advisor Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 119,123 shares of PFE stock, worth $3.19 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
119,123
Previous 192,028 37.97%
Holding current value
$3.19 Million
Previous $5.37 Million 35.83%
% of portfolio
0.09%
Previous 0.16%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $2.02 Million - $2.29 Million
-72,905 Reduced 37.97%
119,123 $3.45 Million
Q2 2024

Jul 16, 2024

BUY
$25.26 - $29.6 $277,683 - $325,392
10,993 Added 6.07%
192,028 $5.37 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $2.71 Million - $3.11 Million
104,502 Added 136.55%
181,035 $5.02 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $1.33 Million - $1.72 Million
-50,713 Reduced 39.85%
76,533 $2.2 Million
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $114,818 - $134,210
3,578 Added 2.89%
127,246 $4.22 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $171,895 - $198,878
4,759 Added 4.0%
123,668 $4.54 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $1.42 Million - $1.85 Million
-36,034 Reduced 23.26%
118,909 $4.85 Million
Q4 2022

Jan 31, 2023

BUY
$41.75 - $54.5 $319,387 - $416,925
7,650 Added 5.19%
154,943 $7.94 Million
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $291,704 - $356,097
6,666 Added 4.74%
147,293 $6.45 Million
Q2 2022

Jul 19, 2022

BUY
$46.53 - $55.17 $1.55 Million - $1.84 Million
33,354 Added 31.09%
140,627 $7.37 Million
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $545,797 - $676,311
-11,930 Reduced 10.01%
107,273 $5.69 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $1.05 Million - $1.55 Million
25,328 Added 26.98%
119,203 $6.85 Million
Q3 2021

Oct 14, 2021

SELL
$39.25 - $50.42 $203,825 - $261,831
-5,193 Reduced 5.24%
93,875 $4.04 Million
Q2 2021

Jul 27, 2021

BUY
$35.91 - $40.68 $119,113 - $134,935
3,317 Added 3.46%
99,068 $3.84 Million
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $662,767 - $747,468
19,790 Added 26.05%
95,751 $3.47 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $151,418 - $192,541
4,524 Added 6.33%
75,961 $2.8 Million
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $149,098 - $174,926
4,696 Added 7.04%
71,437 $2.62 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $552,581 - $670,362
18,346 Added 37.91%
66,741 $2.18 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $26,192 - $37,422
969 Added 2.04%
48,395 $1.58 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $8,625 - $9,788
-262 Reduced 0.55%
47,426 $1.86 Million
Q3 2019

Oct 25, 2019

SELL
$32.49 - $42.13 $375,097 - $486,390
-11,545 Reduced 19.49%
47,688 $1.71 Million
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $1.07 Million - $1.2 Million
28,956 Added 95.64%
59,233 $2.57 Million
Q1 2019

Apr 26, 2019

BUY
$37.5 - $41.2 $179,025 - $196,688
4,774 Added 18.72%
30,277 $1.29 Million
Q4 2018

Apr 11, 2019

BUY
$38.47 - $43.86 $981,100 - $1.12 Million
25,503 New
25,503 $1.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.